2024 Pan Pacific Lymphoma Conference

The Pan Pacific Lymphoma Conference took place July 15-19, 2024 in Lahaina, HI, and featured clinical updates and research in the areas of lymphoma and transplantation.

Treatment-Actionable Mutation in PTCL Identified

The data herein supports the novel role of mutant CCR4 in enhancing T-cell lymphomagenesis and T-helper differentiation.

Bispecific Antibody Produces Response in CLL With Richter Transformation

These highly encouraging data support further evaluation of epcoritamab.

NX-5948 Shows Early Promise in CLL After BTKi Failure

NX-5948 showed tolerable safety and promising responses in patients with relapsed or refractory CLL or non-Hodgkin lymphoma.

Retrospective Study Asks Which BTK Inhibitor Has the Best Safety, Efficacy

Acalabrutinib and zanubrutinib demonstrated better safety and efficacy outcomes when compared with ibrutinib in CLL/SLL.